Medtronic plc (NYSE:MDT) announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Med-tech company Medtronic (MDT) announced on Tuesday that its board of directors has appointed industry veterans John ...

Medtronic said on Tuesday it would add two new directors to its board and set up committees to help boost its lagging shares, ...

John P. Groetelaars served as President, CEO and a Board member at Hillrom from May 2018 until the company’ s acquisition by Baxter International, Inc., in December 2021. Mr. Groetelaars led a ...

Medtronic has appointed John Groetelaars and Bill Jellison to its board as independent directors, effective immediately, and formed two board committees.

John Groetelaars served as President, CEO and a Board member at Hillrom from May 2018 until the company’s acquisition by Baxter International, Inc., in December 2021.

by Benzinga Newsdesk, Benzinga Staff Writer April 19, 2022 8:42 AM | 18 seconds read ...

John Groetelaars And then, David, to your question on Bardy, as we’ve said in our opening comments, our prepared comments, we’re continuing to monitor the reimbursement situation closely.

John Groetelaars Yes. Barbara Bodem Okay. So David, I’m sorry to repeat, if you heard it the first time through. But our level of incremental investment in ‘21 is very consistent with ‘20.